The development and implementation of a quality assurance Master Audit Plan

Area of Science:

• Clinical research quality assurance
• Regulatory compliance in clinical trials
• Pharmaceutical quality management

Background:

• Quality Assurance (QA) departments in clinical research organizations (CROs) perform critical audit functions for clinical trials.
• A Master Audit Plan (MAP) is essential for ensuring quality and regulatory compliance throughout study timelines.
• MAPs encompass diverse QA activities, including regulatory document review and site audits.

Purpose of the Study:

• To compile and analyze results from major QA tasks within clinical trials.
• To identify common areas of non-compliance in test article release, informed consent, and site audits.
• To assess adherence to Federal regulations and Good Clinical Practice (GCP) guidelines.

Main Methods:

• Development and implementation of a Master Audit Plan (MAP) for each clinical study or independent audit task.
• Systematic review of regulatory documents for test article release.
• Evaluation of informed consent forms for accuracy and completeness.
• Conducting clinical site audits to assess adherence to protocols and regulations.

Main Results:

• 13% of regulatory document files reviewed for test article release required additional documentation or corrections.
• 32% of informed consents reviewed necessitated revisions.
• Clinical site audits indicated general adherence to Federal regulations and GCP guidelines, with common observations in test article accountability, documentation, and quality control.

Conclusions:

• While clinical sites generally comply with regulations, specific areas like test article release and informed consent require focused QA attention.
• The Master Audit Plan (MAP) effectively identifies quality and compliance issues across various clinical trial activities.
• Continuous monitoring and improvement of QA processes are crucial for maintaining data integrity and patient safety in clinical research.